The combination of ethambutol, capreomycin and a third drug in chronic pulmonary tuberculosis with bacterial polyresistance.
D000284:Administration, Oral; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002207:Capreomycin / Q000627:therapeutic use; D002908:Chronic Disease / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003523:Cycloserine / Q000627:therapeutic use; D004338:Drug Combinations; D004977:Ethambutol / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008875:Middle Aged; D010403:Penicillin Resistance; D010406:Penicillins / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D011859:Radiography; D013752:Tetracycline / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D004338:Drug Combinations; D010406:Penicillins; D002207:Capreomycin; D011718:Pyrazinamide; D004977:Ethambutol; D003523:Cycloserine; D013752:Tetracycline